UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 21, 2025
Accession Number:
0001214659-25-016809
Submission Type:
POS AM
CIK:
0001643918
Company Name:
Biodexa Pharmaceuticals Plc
File Number:
333-272693